Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Bio-Works Technologies AB Statistics

Total Valuation

NGM:BIOWKS has a market cap or net worth of SEK 294.30 million. The enterprise value is 259.36 million.

Market Cap	294.30M
Enterprise Value	259.36M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

NGM:BIOWKS has 99.42 million shares outstanding. The number of shares has increased by 65.69% in one year.

Current Share Class	99.42M
Shares Outstanding	99.42M
Shares Change (YoY)	+65.69%
Shares Change (QoQ)	+31.71%
Owned by Insiders (%)	20.39%
Owned by Institutions (%)	8.41%
Float	59.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.66
PB Ratio	5.98
P/TBV Ratio	5.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.01
EV / Sales	4.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.50

Financial Position

The company has a current ratio of 3.20

Current Ratio	3.20
Quick Ratio	2.35
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-90.77

Financial Efficiency

Return on equity (ROE) is -32.51% and return on invested capital (ROIC) is -23.35%.

Return on Equity (ROE)	-32.51%
Return on Assets (ROA)	-17.77%
Return on Invested Capital (ROIC)	-23.35%
Return on Capital Employed (ROCE)	-35.60%
Weighted Average Cost of Capital (WACC)	10.21%
Revenue Per Employee	2.43M
Profits Per Employee	-586,423
Employee Count	29
Asset Turnover	1.02
Inventory Turnover	1.14

Taxes

Income Tax	-1.92M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +113.72% in the last 52 weeks. The beta is 1.08, so NGM:BIOWKS's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	+113.72%
50-Day Moving Average	2.74
200-Day Moving Average	2.39
Relative Strength Index (RSI)	54.29
Average Volume (20 Days)	121,281

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NGM:BIOWKS had revenue of SEK 63.11 million and -15.25 million in losses. Loss per share was -0.18.

Revenue	63.11M
Gross Profit	48.41M
Operating Income	-17.52M
Pretax Income	-17.16M
Net Income	-15.25M
EBITDA	-17.01M
EBIT	-17.52M
Loss Per Share	-0.18

Balance Sheet

The company has 34.93 million in cash and n/a in debt, with a net cash position of 34.93 million or 0.35 per share.

Cash & Cash Equivalents	34.93M
Total Debt	n/a
Net Cash	34.93M
Net Cash Per Share	0.35
Equity (Book Value)	49.21M
Book Value Per Share	0.50
Working Capital	47.50M

Cash Flow

In the last 12 months, operating cash flow was -18.81 million and capital expenditures -404,000, giving a free cash flow of -19.22 million.

Operating Cash Flow	-18.81M
Capital Expenditures	-404,000
Free Cash Flow	-19.22M
FCF Per Share	-0.19

Margins

Gross margin is 76.71%, with operating and profit margins of -27.76% and -24.16%.

Gross Margin	76.71%
Operating Margin	-27.76%
Pretax Margin	-27.20%
Profit Margin	-24.16%
EBITDA Margin	-26.95%
EBIT Margin	-27.76%
FCF Margin	n/a

Dividends & Yields

NGM:BIOWKS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-65.69%
Shareholder Yield	-65.69%
Earnings Yield	-5.18%
FCF Yield	-6.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NGM:BIOWKS has an Altman Z-Score of -1.72 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.72
Piotroski F-Score	1